5 citations
,
September 2021 in “Dermatology Reports” This study found that acne, hirsutism, and other skin conditions are prevalent among Jordanian women with polycystic ovary syndrome, often linked to specific hormonal imbalances and higher BMI.
4 citations
,
December 2021 in “Clinical and Experimental Reproductive Medicine” This study found that women with PCOS who had a higher serum estrone-to-estradiol ratio were more likely to exhibit higher fasting insulin and postprandial glucose levels, even after adjusting for BMI and waist-to-hip ratio.
3 citations
,
September 2023 in “Cosmetics” This study found that training in a hypoxic chamber did not significantly impact skin features in overweight and obese women, though it did result in a notable reduction in body weight and BMI.
2 citations
,
January 2025 in “JBRA” This study concludes that age has a substantial impact on live birth rates in IVF, more so than BMI, while cumulative live birth rate is the most informative measure of reproductive success.
2 citations
,
November 2023 in “Global Advances in Integrative Medicine and Health” In this study, the authors reported preliminary evidence that programs combining nutrition and exercise interventions can significantly reduce BMI and LDL levels, suggesting these elements are important for lifestyle modification.
2 citations
,
July 2023 in “Frontiers in Endocrinology” This review identified and evaluated polycystic ovary syndrome models of care, finding that only three fully aligned with international guidelines and generally received positive feedback on satisfaction; just one showed an impact on patients' BMI.
1 citations
,
July 2011 in “Climacteric” Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.
June 2026 in “Journal of Pakistan Association of Dermatologists” This study found a significant correlation between lower triglyceride levels and reduced acne severity among medical students, while no significant association was observed between BMI and acne severity.
May 2026 in “AlQalam Journal of Medical and Applied Sciences” In this study, researchers found that relying solely on ferritin to assess iron status in young females with higher BMI may lead to inaccurate diagnoses of iron deficiency due to inflammation-related ferritin elevation.
In this prospective observational study at a tertiary care center in Uttar Pradesh, researchers observed that comprehensive, individualized treatments significantly improved clinical outcomes for South Asian women with PCOS, including reductions in BMI and improvements in insulin sensitivity, ovulation, and pregnancy rates.
April 2025 in “British Journal of Dermatology” This study identified three genetic loci influencing hair density in East Asian populations and found associations with demographic and lifestyle factors like age, sex, and BMI. The results also suggest possible genotype-specific responses to finasteride for managing hair disorders.
This study in women aged 28-38 after their first cesarean delivery found higher levels of inflammatory markers and metabolic disturbances, including elevated BMI and blood sugar, which may contribute to increased postpartum hair loss compared to healthy controls.
March 2025 in “Global Journal For Research Analysis” This study found a high prevalence of hair loss among medical students, primarily linked to stress, while factors such as BMI and hemoglobin levels showed no significant correlation.
January 2025 in “Journal of Clinical Medicine” This study found that among Portuguese women with hirsutism, polycystic ovary syndrome was the most prevalent cause, associated with distinct hormonal features and higher BMI compared to controls.
December 2024 in “International Journal of Advanced Research” In this study, the authors concluded that metformin and vitamin D are important for managing PCOS by improving insulin resistance and hormonal imbalances, especially in women with a BMI of 25 kg/m² or higher.
June 2024 in “International Journal of Ayurveda and Pharma Research” In this study involving 40 PCOS patients, the authors observed notable improvements in menstrual cycle regularity and ovarian cyst volume reduction using Tila kashayam and Shatapuspa choornam treatments, though they reported no significant changes in hirsutism, BMI, or waist circumference over three months.
In this study, nearly 38% of Saudi women with PCOS reported extremely severe depression and extreme anxiety, with higher rates linked to young age, divorce, lifestyle advice, and higher BMI.
December 2023 in “Advances in basic medical sciences.” In this cohort study, short-term treatment with metformin in overweight/obese women with PCOS significantly improved menstrual irregularities and lipid profiles (HDL and LDL levels), but did not significantly affect BMI, insulin, testosterone, or adipokine levels compared to the unexposed group.
September 2023 in “Journal of the turkish academy of dermatology” In this study, researchers found that men with androgenetic alopecia had higher obesity-related parameters, such as fat percentage and BMI, compared to healthy controls, but observed no differences in cardiovascular markers like CIMT and EFT.
December 2022 in “Türk biyokimya dergisi” The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.
January 2021 in “Benha Journal of Applied Sciences” This study found no significant difference in serum prolactin levels between vitiligo patients and healthy controls, nor any significant association between prolactin gene polymorphism and vitiligo severity, except for a significant relation with BMI.
July 2020 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that adding pioglitazone to either spironolactone or metformin improved metabolic parameters and insulin resistance in women with PCOS, despite an increase in BMI.
This thesis suggests that for individuals with Lynch syndrome, factors such as dietary inflammatory potential and height do not significantly influence tumor development, while higher BMI at a young age may increase cancer risk in women.
February 2017 in “The Journal of Sexual Medicine” In this controlled registry study, 8 years of testosterone therapy in hypogonadal men led to a significant decrease in waist circumference, weight, and BMI compared to those without the therapy.
July 2018 in “Benha Journal of Applied Sciences” This study found that patients with androgenetic alopecia had higher serum homocysteine levels, which were positively correlated with BMI and smoking, suggesting it could be an early predictor for AGA diagnosis.
3 citations
,
May 2025 in “Archives of Gynecology and Obstetrics” In this study, researchers reported that women with polycystic ovary syndrome in a German-speaking population had higher probabilities of depression, anxiety, sleep disorders, and obstructive sleep apnea, all associated with BMI and insulin resistance.
October 2024 in “South Eastern European Journal of Public Health” This study on women aged 18–40 with polycystic ovary syndrome reported that a three-month treatment involving dietary changes, oral contraceptives, fertility drugs, and supplements significantly improved ovulation, menstrual regularity, BMI, and reduced hirsutism, acne, and certain immune factors compared to pre-treatment and control groups.
October 2017 in “Journal of medical science and clinical research” This study found that obese individuals commonly experienced skin manifestations such as acanthosis nigricans, hyperandrogenism features, and increased cutaneous infections compared to non-obese individuals.
December 2024 in “American Journal of Case Reports” This case report highlights that insulin resistance in PCOS can occur even in underweight patients, as demonstrated by a 24-year-old woman who improved her menstrual cycle, acne, and hirsutism with metformin and dexamethasone over 6 months.
June 2024 in “Biological and Clinical Sciences Research Journal” In this study, researchers found that women with PCOS and thyroid dysfunction had significantly altered T3 and T4 hormone levels and more frequent symptoms like weight gain and irregular menstrual cycles, suggesting the importance of thyroid screenings for personalized treatment strategies.